Click for best price
Compounded Bioidentical Hormone Therapy Market Size, Share 2023
Bioidentical hormones are artificial hormones that are chemically similar to those naturallyproduced by the human body. Because they are chemically similar to the hormones produced by the body, bioidentical hormones act as the body's own hormones with very few side effects.
This report aims to provide a comprehensive presentation of the global market for Compounded Bioidentical Hormone Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Compounded Bioidentical Hormone Therapy. This report contains market size and forecasts of Compounded Bioidentical Hormone Therapy in global, including the following market information:
Global Compounded Bioidentical Hormone Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Compounded Bioidentical Hormone Therapy Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Compounded Bioidentical Hormone Therapy companies in 2022 (%)
The global Compounded Bioidentical Hormone Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Oestrogen Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Compounded Bioidentical Hormone Therapy include SottoPelle, BioTE Medical, Advantage Pharmaceuticals, Full Life Wellness Center, Neuva Aesthetics, Defy Medical, Bio station, Noven Pharmaceuticals and Novartis AG, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Compounded Bioidentical Hormone Therapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Compounded Bioidentical Hormone Therapy Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Compounded Bioidentical Hormone Therapy Market Segment Percentages, by Type, 2022 (%)
Oestrogen
Progesterone
Testosterone
Global Compounded Bioidentical Hormone Therapy Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Compounded Bioidentical Hormone Therapy Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Global Compounded Bioidentical Hormone Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Compounded Bioidentical Hormone Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Compounded Bioidentical Hormone Therapy revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Compounded Bioidentical Hormone Therapy revenues share in global market, 2022 (%)
Key companies Compounded Bioidentical Hormone Therapy sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Compounded Bioidentical Hormone Therapy sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
SottoPelle
BioTE Medical
Advantage Pharmaceuticals
Full Life Wellness Center
Neuva Aesthetics
Defy Medical
Bio station
Noven Pharmaceuticals
Novartis AG
Pfizer
TherapeuticsMD
Bayer AG
Novo Nordisk
Outline of Major Chapters:
Chapter 1: Introduces the definition of Compounded Bioidentical Hormone Therapy, market overview.
Chapter 2: Global Compounded Bioidentical Hormone Therapy market size in revenue and volume.
Chapter 3: Detailed analysis of Compounded Bioidentical Hormone Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Compounded Bioidentical Hormone Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Compounded Bioidentical Hormone Therapy capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Compounded Bioidentical Hormone Therapy Market, Global Outlook and Forecast 2023-2032 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
72 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Compounded Bioidentical Hormone Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Compounded Bioidentical Hormone Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Compounded Bioidentical Hormone Therapy Overall Market Size
2.1 Global Compounded Bioidentical Hormone Therapy Market Size: 2022 VS 2032
2.2 Global Compounded Bioidentical Hormone Therapy Revenue, Prospects & Forecasts: 2018-2032
2.3 Global Compounded Bioidentical Hormone Therapy Sales: 2018-2032
3 Company Landscape
3.1 Top Compounded Bioidentical Hormone Therapy Players in Global Market
3.2 Top Global Compounded Bioidentical Hormone Therapy Companies Ranked by Revenue
3.3 Global Compounded Bioidentical Hormone Therapy Revenue by Companies
3.4 Global Compounded Bioidentical Hormone Therapy Sales by Companies
3.5 Global Compounded Bioidentical Hormone Therapy Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Compounded Bioidentical Hormone Therapy Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Compounded Bioidentical Hormone Therapy Product Type
3.8 Tier 1, Tier 2 and Tier 3 Compounded Bioidentical Hormone Therapy Players in Global Market
3.8.1 List of Global Tier 1 Compounded Bioidentical Hormone Therapy Companies
3.8.2 List of Global Tier 2 and Tier 3 Compounded Bioidentical Hormone Therapy Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Compounded Bioidentical Hormone Therapy Market Size Markets, 2022 & 2032
4.1.2 Oestrogen
4.1.3 Progesterone
4.1.4 Testosterone
4.2 By Type - Global Compounded Bioidentical Hormone Therapy Revenue & Forecasts
4.2.1 By Type - Global Compounded Bioidentical Hormone Therapy Revenue, 2018-2023
4.2.2 By Type - Global Compounded Bioidentical Hormone Therapy Revenue, 2024-2032
4.2.3 By Type - Global Compounded Bioidentical Hormone Therapy Revenue Market Share, 2018-2032
4.3 By Type - Global Compounded Bioidentical Hormone Therapy Sales & Forecasts
4.3.1 By Type - Global Compounded Bioidentical Hormone Therapy Sales, 2018-2023
4.3.2 By Type - Global Compounded Bioidentical Hormone Therapy Sales, 2024-2032
4.3.3 By Type - Global Compounded Bioidentical Hormone Therapy Sales Market Share, 2018-2032
4.4 By Type - Global Compounded Bioidentical Hormone Therapy Price (Manufacturers Selling Prices), 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Compounded Bioidentical Hormone Therapy Market Size, 2022 & 2032
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.1.5 Others
5.2 By Application - Global Compounded Bioidentical Hormone Therapy Revenue & Forecasts
5.2.1 By Application - Global Compounded Bioidentical Hormone Therapy Revenue, 2018-2023
5.2.2 By Application - Global Compounded Bioidentical Hormone Therapy Revenue, 2024-2032
5.2.3 By Application - Global Compounded Bioidentical Hormone Therapy Revenue Market Share, 2018-2032
5.3 By Application - Global Compounded Bioidentical Hormone Therapy Sales & Forecasts
5.3.1 By Application - Global Compounded Bioidentical Hormone Therapy Sales, 2018-2023
5.3.2 By Application - Global Compounded Bioidentical Hormone Therapy Sales, 2024-2032
5.3.3 By Application - Global Compounded Bioidentical Hormone Therapy Sales Market Share, 2018-2032
5.4 By Application - Global Compounded Bioidentical Hormone Therapy Price (Manufacturers Selling Prices), 2018-2032
6 Sights by Region
6.1 By Region - Global Compounded Bioidentical Hormone Therapy Market Size, 2022 & 2032
6.2 By Region - Global Compounded Bioidentical Hormone Therapy Revenue & Forecasts
6.2.1 By Region - Global Compounded Bioidentical Hormone Therapy Revenue, 2018-2023
6.2.2 By Region - Global Compounded Bioidentical Hormone Therapy Revenue, 2024-2032
6.2.3 By Region - Global Compounded Bioidentical Hormone Therapy Revenue Market Share, 2018-2032
6.3 By Region - Global Compounded Bioidentical Hormone Therapy Sales & Forecasts
6.3.1 By Region - Global Compounded Bioidentical Hormone Therapy Sales, 2018-2023
6.3.2 By Region - Global Compounded Bioidentical Hormone Therapy Sales, 2024-2032
6.3.3 By Region - Global Compounded Bioidentical Hormone Therapy Sales Market Share, 2018-2032
6.4 North America
6.4.1 By Country - North America Compounded Bioidentical Hormone Therapy Revenue, 2018-2032
6.4.2 By Country - North America Compounded Bioidentical Hormone Therapy Sales, 2018-2032
6.4.3 US Compounded Bioidentical Hormone Therapy Market Size, 2018-2032
6.4.4 Canada Compounded Bioidentical Hormone Therapy Market Size, 2018-2032
6.4.5 Mexico Compounded Bioidentical Hormone Therapy Market Size, 2018-2032
6.5 Europe
6.5.1 By Country - Europe Compounded Bioidentical Hormone Therapy Revenue, 2018-2032
6.5.2 By Country - Europe Compounded Bioidentical Hormone Therapy Sales, 2018-2032
6.5.3 Germany Compounded Bioidentical Hormone Therapy Market Size, 2018-2032
6.5.4 France Compounded Bioidentical Hormone Therapy Market Size, 2018-2032
6.5.5 U.K. Compounded Bioidentical Hormone Therapy Market Size, 2018-2032
6.5.6 Italy Compounded Bioidentical Hormone Therapy Market Size, 2018-2032
6.5.7 Russia Compounded Bioidentical Hormone Therapy Market Size, 2018-2032
6.5.8 Nordic Countries Compounded Bioidentical Hormone Therapy Market Size, 2018-2032
6.5.9 Benelux Compounded Bioidentical Hormone Therapy Market Size, 2018-2032
6.6 Asia
6.6.1 By Region - Asia Compounded Bioidentical Hormone Therapy Revenue, 2018-2032
6.6.2 By Region - Asia Compounded Bioidentical Hormone Therapy Sales, 2018-2032
6.6.3 China Compounded Bioidentical Hormone Therapy Market Size, 2018-2032
6.6.4 Japan Compounded Bioidentical Hormone Therapy Market Size, 2018-2032
6.6.5 South Korea Compounded Bioidentical Hormone Therapy Market Size, 2018-2032
6.6.6 Southeast Asia Compounded Bioidentical Hormone Therapy Market Size, 2018-2032
6.6.7 India Compounded Bioidentical Hormone Therapy Market Size, 2018-2032
6.7 South America
6.7.1 By Country - South America Compounded Bioidentical Hormone Therapy Revenue, 2018-2032
6.7.2 By Country - South America Compounded Bioidentical Hormone Therapy Sales, 2018-2032
6.7.3 Brazil Compounded Bioidentical Hormone Therapy Market Size, 2018-2032
6.7.4 Argentina Compounded Bioidentical Hormone Therapy Market Size, 2018-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Compounded Bioidentical Hormone Therapy Revenue, 2018-2032
6.8.2 By Country - Middle East & Africa Compounded Bioidentical Hormone Therapy Sales, 2018-2032
6.8.3 Turkey Compounded Bioidentical Hormone Therapy Market Size, 2018-2032
6.8.4 Israel Compounded Bioidentical Hormone Therapy Market Size, 2018-2032
6.8.5 Saudi Arabia Compounded Bioidentical Hormone Therapy Market Size, 2018-2032
6.8.6 UAE Compounded Bioidentical Hormone Therapy Market Size, 2018-2032
7 Manufacturers & Brands Profiles
7.1 SottoPelle
7.1.1 SottoPelle Company Summary
7.1.2 SottoPelle Business Overview
7.1.3 SottoPelle Compounded Bioidentical Hormone Therapy Major Product Offerings
7.1.4 SottoPelle Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2018-2023)
7.1.5 SottoPelle Key News & Latest Developments
7.2 BioTE Medical
7.2.1 BioTE Medical Company Summary
7.2.2 BioTE Medical Business Overview
7.2.3 BioTE Medical Compounded Bioidentical Hormone Therapy Major Product Offerings
7.2.4 BioTE Medical Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2018-2023)
7.2.5 BioTE Medical Key News & Latest Developments
7.3 Advantage Pharmaceuticals
7.3.1 Advantage Pharmaceuticals Company Summary
7.3.2 Advantage Pharmaceuticals Business Overview
7.3.3 Advantage Pharmaceuticals Compounded Bioidentical Hormone Therapy Major Product Offerings
7.3.4 Advantage Pharmaceuticals Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2018-2023)
7.3.5 Advantage Pharmaceuticals Key News & Latest Developments
7.4 Full Life Wellness Center
7.4.1 Full Life Wellness Center Company Summary
7.4.2 Full Life Wellness Center Business Overview
7.4.3 Full Life Wellness Center Compounded Bioidentical Hormone Therapy Major Product Offerings
7.4.4 Full Life Wellness Center Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2018-2023)
7.4.5 Full Life Wellness Center Key News & Latest Developments
7.5 Neuva Aesthetics
7.5.1 Neuva Aesthetics Company Summary
7.5.2 Neuva Aesthetics Business Overview
7.5.3 Neuva Aesthetics Compounded Bioidentical Hormone Therapy Major Product Offerings
7.5.4 Neuva Aesthetics Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2018-2023)
7.5.5 Neuva Aesthetics Key News & Latest Developments
7.6 Defy Medical
7.6.1 Defy Medical Company Summary
7.6.2 Defy Medical Business Overview
7.6.3 Defy Medical Compounded Bioidentical Hormone Therapy Major Product Offerings
7.6.4 Defy Medical Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2018-2023)
7.6.5 Defy Medical Key News & Latest Developments
7.7 Bio station
7.7.1 Bio station Company Summary
7.7.2 Bio station Business Overview
7.7.3 Bio station Compounded Bioidentical Hormone Therapy Major Product Offerings
7.7.4 Bio station Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2018-2023)
7.7.5 Bio station Key News & Latest Developments
7.8 Noven Pharmaceuticals
7.8.1 Noven Pharmaceuticals Company Summary
7.8.2 Noven Pharmaceuticals Business Overview
7.8.3 Noven Pharmaceuticals Compounded Bioidentical Hormone Therapy Major Product Offerings
7.8.4 Noven Pharmaceuticals Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2018-2023)
7.8.5 Noven Pharmaceuticals Key News & Latest Developments
7.9 Novartis AG
7.9.1 Novartis AG Company Summary
7.9.2 Novartis AG Business Overview
7.9.3 Novartis AG Compounded Bioidentical Hormone Therapy Major Product Offerings
7.9.4 Novartis AG Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2018-2023)
7.9.5 Novartis AG Key News & Latest Developments
7.10 Pfizer
7.10.1 Pfizer Company Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Compounded Bioidentical Hormone Therapy Major Product Offerings
7.10.4 Pfizer Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2018-2023)
7.10.5 Pfizer Key News & Latest Developments
7.11 TherapeuticsMD
7.11.1 TherapeuticsMD Company Summary
7.11.2 TherapeuticsMD Compounded Bioidentical Hormone Therapy Business Overview
7.11.3 TherapeuticsMD Compounded Bioidentical Hormone Therapy Major Product Offerings
7.11.4 TherapeuticsMD Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2018-2023)
7.11.5 TherapeuticsMD Key News & Latest Developments
7.12 Bayer AG
7.12.1 Bayer AG Company Summary
7.12.2 Bayer AG Compounded Bioidentical Hormone Therapy Business Overview
7.12.3 Bayer AG Compounded Bioidentical Hormone Therapy Major Product Offerings
7.12.4 Bayer AG Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2018-2023)
7.12.5 Bayer AG Key News & Latest Developments
7.13 Novo Nordisk
7.13.1 Novo Nordisk Company Summary
7.13.2 Novo Nordisk Compounded Bioidentical Hormone Therapy Business Overview
7.13.3 Novo Nordisk Compounded Bioidentical Hormone Therapy Major Product Offerings
7.13.4 Novo Nordisk Compounded Bioidentical Hormone Therapy Sales and Revenue in Global (2018-2023)
7.13.5 Novo Nordisk Key News & Latest Developments
8 Global Compounded Bioidentical Hormone Therapy Production Capacity, Analysis
8.1 Global Compounded Bioidentical Hormone Therapy Production Capacity, 2018-2032
8.2 Compounded Bioidentical Hormone Therapy Production Capacity of Key Manufacturers in Global Market
8.3 Global Compounded Bioidentical Hormone Therapy Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Compounded Bioidentical Hormone Therapy Supply Chain Analysis
10.1 Compounded Bioidentical Hormone Therapy Industry Value Chain
10.2 Compounded Bioidentical Hormone Therapy Upstream Market
10.3 Compounded Bioidentical Hormone Therapy Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Compounded Bioidentical Hormone Therapy Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Compounded Bioidentical Hormone Therapy in Global Market
Table 2. Top Compounded Bioidentical Hormone Therapy Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Compounded Bioidentical Hormone Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Compounded Bioidentical Hormone Therapy Revenue Share by Companies, 2018-2023
Table 5. Global Compounded Bioidentical Hormone Therapy Sales by Companies, (K Units), 2018-2023
Table 6. Global Compounded Bioidentical Hormone Therapy Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Compounded Bioidentical Hormone Therapy Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Compounded Bioidentical Hormone Therapy Product Type
Table 9. List of Global Tier 1 Compounded Bioidentical Hormone Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Compounded Bioidentical Hormone Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Global Compounded Bioidentical Hormone Therapy Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Compounded Bioidentical Hormone Therapy Revenue (US$, Mn), 2024-2032
Table 14. By Type - Global Compounded Bioidentical Hormone Therapy Sales (K Units), 2018-2023
Table 15. By Type - Global Compounded Bioidentical Hormone Therapy Sales (K Units), 2024-2032
Table 16. By Application ? Global Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2022 & 2032
Table 17. By Application - Global Compounded Bioidentical Hormone Therapy Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Compounded Bioidentical Hormone Therapy Revenue (US$, Mn), 2024-2032
Table 19. By Application - Global Compounded Bioidentical Hormone Therapy Sales (K Units), 2018-2023
Table 20. By Application - Global Compounded Bioidentical Hormone Therapy Sales (K Units), 2024-2032
Table 21. By Region ? Global Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2022 VS 2032
Table 22. By Region - Global Compounded Bioidentical Hormone Therapy Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Compounded Bioidentical Hormone Therapy Revenue (US$, Mn), 2024-2032
Table 24. By Region - Global Compounded Bioidentical Hormone Therapy Sales (K Units), 2018-2023
Table 25. By Region - Global Compounded Bioidentical Hormone Therapy Sales (K Units), 2024-2032
Table 26. By Country - North America Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2024-2032
Table 28. By Country - North America Compounded Bioidentical Hormone Therapy Sales, (K Units), 2018-2023
Table 29. By Country - North America Compounded Bioidentical Hormone Therapy Sales, (K Units), 2024-2032
Table 30. By Country - Europe Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2024-2032
Table 32. By Country - Europe Compounded Bioidentical Hormone Therapy Sales, (K Units), 2018-2023
Table 33. By Country - Europe Compounded Bioidentical Hormone Therapy Sales, (K Units), 2024-2032
Table 34. By Region - Asia Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2024-2032
Table 36. By Region - Asia Compounded Bioidentical Hormone Therapy Sales, (K Units), 2018-2023
Table 37. By Region - Asia Compounded Bioidentical Hormone Therapy Sales, (K Units), 2024-2032
Table 38. By Country - South America Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2024-2032
Table 40. By Country - South America Compounded Bioidentical Hormone Therapy Sales, (K Units), 2018-2023
Table 41. By Country - South America Compounded Bioidentical Hormone Therapy Sales, (K Units), 2024-2032
Table 42. By Country - Middle East & Africa Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2024-2032
Table 44. By Country - Middle East & Africa Compounded Bioidentical Hormone Therapy Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Compounded Bioidentical Hormone Therapy Sales, (K Units), 2024-2032
Table 46. SottoPelle Company Summary
Table 47. SottoPelle Compounded Bioidentical Hormone Therapy Product Offerings
Table 48. SottoPelle Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. SottoPelle Key News & Latest Developments
Table 50. BioTE Medical Company Summary
Table 51. BioTE Medical Compounded Bioidentical Hormone Therapy Product Offerings
Table 52. BioTE Medical Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. BioTE Medical Key News & Latest Developments
Table 54. Advantage Pharmaceuticals Company Summary
Table 55. Advantage Pharmaceuticals Compounded Bioidentical Hormone Therapy Product Offerings
Table 56. Advantage Pharmaceuticals Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Advantage Pharmaceuticals Key News & Latest Developments
Table 58. Full Life Wellness Center Company Summary
Table 59. Full Life Wellness Center Compounded Bioidentical Hormone Therapy Product Offerings
Table 60. Full Life Wellness Center Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Full Life Wellness Center Key News & Latest Developments
Table 62. Neuva Aesthetics Company Summary
Table 63. Neuva Aesthetics Compounded Bioidentical Hormone Therapy Product Offerings
Table 64. Neuva Aesthetics Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Neuva Aesthetics Key News & Latest Developments
Table 66. Defy Medical Company Summary
Table 67. Defy Medical Compounded Bioidentical Hormone Therapy Product Offerings
Table 68. Defy Medical Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Defy Medical Key News & Latest Developments
Table 70. Bio station Company Summary
Table 71. Bio station Compounded Bioidentical Hormone Therapy Product Offerings
Table 72. Bio station Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Bio station Key News & Latest Developments
Table 74. Noven Pharmaceuticals Company Summary
Table 75. Noven Pharmaceuticals Compounded Bioidentical Hormone Therapy Product Offerings
Table 76. Noven Pharmaceuticals Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Noven Pharmaceuticals Key News & Latest Developments
Table 78. Novartis AG Company Summary
Table 79. Novartis AG Compounded Bioidentical Hormone Therapy Product Offerings
Table 80. Novartis AG Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Novartis AG Key News & Latest Developments
Table 82. Pfizer Company Summary
Table 83. Pfizer Compounded Bioidentical Hormone Therapy Product Offerings
Table 84. Pfizer Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Pfizer Key News & Latest Developments
Table 86. TherapeuticsMD Company Summary
Table 87. TherapeuticsMD Compounded Bioidentical Hormone Therapy Product Offerings
Table 88. TherapeuticsMD Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. TherapeuticsMD Key News & Latest Developments
Table 90. Bayer AG Company Summary
Table 91. Bayer AG Compounded Bioidentical Hormone Therapy Product Offerings
Table 92. Bayer AG Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Bayer AG Key News & Latest Developments
Table 94. Novo Nordisk Company Summary
Table 95. Novo Nordisk Compounded Bioidentical Hormone Therapy Product Offerings
Table 96. Novo Nordisk Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Novo Nordisk Key News & Latest Developments
Table 98. Compounded Bioidentical Hormone Therapy Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 99. Global Compounded Bioidentical Hormone Therapy Capacity Market Share of Key Manufacturers, 2021-2023
Table 100. Global Compounded Bioidentical Hormone Therapy Production by Region, 2018-2023 (K Units)
Table 101. Global Compounded Bioidentical Hormone Therapy Production by Region, 2024-2032 (K Units)
Table 102. Compounded Bioidentical Hormone Therapy Market Opportunities & Trends in Global Market
Table 103. Compounded Bioidentical Hormone Therapy Market Drivers in Global Market
Table 104. Compounded Bioidentical Hormone Therapy Market Restraints in Global Market
Table 105. Compounded Bioidentical Hormone Therapy Raw Materials
Table 106. Compounded Bioidentical Hormone Therapy Raw Materials Suppliers in Global Market
Table 107. Typical Compounded Bioidentical Hormone Therapy Downstream
Table 108. Compounded Bioidentical Hormone Therapy Downstream Clients in Global Market
Table 109. Compounded Bioidentical Hormone Therapy Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Compounded Bioidentical Hormone Therapy Segment by Type in 2022
Figure 2. Compounded Bioidentical Hormone Therapy Segment by Application in 2022
Figure 3. Global Compounded Bioidentical Hormone Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Compounded Bioidentical Hormone Therapy Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Compounded Bioidentical Hormone Therapy Revenue, 2018-2032 (US$, Mn)
Figure 7. Compounded Bioidentical Hormone Therapy Sales in Global Market: 2018-2032 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Compounded Bioidentical Hormone Therapy Revenue in 2022
Figure 9. By Type - Global Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2022 & 2032
Figure 10. By Type - Global Compounded Bioidentical Hormone Therapy Revenue Market Share, 2018-2032
Figure 11. By Type - Global Compounded Bioidentical Hormone Therapy Sales Market Share, 2018-2032
Figure 12. By Type - Global Compounded Bioidentical Hormone Therapy Price (US$/Unit), 2018-2032
Figure 13. By Application - Global Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2022 & 2032
Figure 14. By Application - Global Compounded Bioidentical Hormone Therapy Revenue Market Share, 2018-2032
Figure 15. By Application - Global Compounded Bioidentical Hormone Therapy Sales Market Share, 2018-2032
Figure 16. By Application - Global Compounded Bioidentical Hormone Therapy Price (US$/Unit), 2018-2032
Figure 17. By Region - Global Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2022 & 2032
Figure 18. By Region - Global Compounded Bioidentical Hormone Therapy Revenue Market Share, 2018 VS 2022 VS 2032
Figure 19. By Region - Global Compounded Bioidentical Hormone Therapy Revenue Market Share, 2018-2032
Figure 20. By Region - Global Compounded Bioidentical Hormone Therapy Sales Market Share, 2018-2032
Figure 21. By Country - North America Compounded Bioidentical Hormone Therapy Revenue Market Share, 2018-2032
Figure 22. By Country - North America Compounded Bioidentical Hormone Therapy Sales Market Share, 2018-2032
Figure 23. US Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2018-2032
Figure 24. Canada Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2018-2032
Figure 25. Mexico Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2018-2032
Figure 26. By Country - Europe Compounded Bioidentical Hormone Therapy Revenue Market Share, 2018-2032
Figure 27. By Country - Europe Compounded Bioidentical Hormone Therapy Sales Market Share, 2018-2032
Figure 28. Germany Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2018-2032
Figure 29. France Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2018-2032
Figure 30. U.K. Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2018-2032
Figure 31. Italy Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2018-2032
Figure 32. Russia Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2018-2032
Figure 33. Nordic Countries Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2018-2032
Figure 34. Benelux Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2018-2032
Figure 35. By Region - Asia Compounded Bioidentical Hormone Therapy Revenue Market Share, 2018-2032
Figure 36. By Region - Asia Compounded Bioidentical Hormone Therapy Sales Market Share, 2018-2032
Figure 37. China Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2018-2032
Figure 38. Japan Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2018-2032
Figure 39. South Korea Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2018-2032
Figure 40. Southeast Asia Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2018-2032
Figure 41. India Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2018-2032
Figure 42. By Country - South America Compounded Bioidentical Hormone Therapy Revenue Market Share, 2018-2032
Figure 43. By Country - South America Compounded Bioidentical Hormone Therapy Sales Market Share, 2018-2032
Figure 44. Brazil Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2018-2032
Figure 45. Argentina Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2018-2032
Figure 46. By Country - Middle East & Africa Compounded Bioidentical Hormone Therapy Revenue Market Share, 2018-2032
Figure 47. By Country - Middle East & Africa Compounded Bioidentical Hormone Therapy Sales Market Share, 2018-2032
Figure 48. Turkey Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2018-2032
Figure 49. Israel Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2018-2032
Figure 50. Saudi Arabia Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2018-2032
Figure 51. UAE Compounded Bioidentical Hormone Therapy Revenue, (US$, Mn), 2018-2032
Figure 52. Global Compounded Bioidentical Hormone Therapy Production Capacity (K Units), 2018-2032
Figure 53. The Percentage of Production Compounded Bioidentical Hormone Therapy by Region, 2022 VS 2032
Figure 54. Compounded Bioidentical Hormone Therapy Industry Value Chain
Figure 55. Marketing Channels
